GlassScriptPhysician profile
Scott Michael Silver
NPI 1891998944
$8,056.03
in general payments reported to CMS, 2019-2025
37 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $745 · 2021: $256 · 2022: $1,638 · 2023: $725 · 2024: $2,107 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,342 · Travel and Lodging: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,342.17 |
| Travel and Lodging | $707.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,899.70 | 2022-2025 | Heli-Fx Endoanchor System, Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $937.34 | 2019-2022 | |
| Endologix LLC | $906.24 | 2023-2025 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft, Endocross Device |
| Inari Medical, INC. | $886.70 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $704.33 | 2019-2025 | Venovo |
| Integra Lifesciences Corporation | $323.82 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cardiovascular Systems INC. | $241.98 | 2019-2022 | |
| Medtronic Vascular, INC. | $234.93 | 2019-2020 | |
| Lemaitre Vascular, INC. | $227.21 | 2022-2025 | Hydro Lemaitre Valvulotome, Restoreflow |
| Terumo Medical Corporation | $206.15 | 2019-2025 | Azur Cx Detachable, Navicross, Angio-Seal |
| Stryker Corporation | $188.69 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $186.25 | 2023-2025 | Cook, Zilver Ptx, Zenith |
| W. L. Gore & Associates, INC. | $127.83 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Pfizer INC. | $112.58 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $92.11 | 2021-2024 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $81.09 | 2021-2025 | Collagenase Santyl |
| Abbott Laboratories | $76.38 | 2023-2025 | Jeti Peripheral Catheter, Esprit, Epic |
| Surmodics, INC. | $75.41 | 2023-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Boston Scientific Corporation | $60.04 | 2022-2023 | Eluvia |
| Angiodynamics, INC. | $57.35 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Peerless Surgical INC. | $42.27 | 2024 | |
| Ethicon INC. | $38.97 | 2024 | Monarch Platform |
| Shockwave Medical, INC | $37.73 | 2021-2025 | |
| Atricure, INC. | $33.90 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Getinge USA Sales, LLC | $30.14 | 2025 | Intergard |
| Davol INC. | $29.76 | 2025 | |
| Csl Behring | $28.75 | 2024 | Kcentra |
| Cardiva Medical, INC. | $27.00 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cagent Vascular INC | $26.80 | 2025 | Serrantor |
| Acera Surgical, INC. | $24.98 | 2025 | Restrata Wound Matrix |
| Imperative Care, INC | $24.34 | 2024 | Prodigy Catheter |
| Avinger INC. | $20.89 | 2022 | |
| Penumbra, INC. | $20.07 | 2021 | |
| Teleflex LLC | $17.98 | 2020 | |
| Balt USA, LLC | $16.87 | 2024 | Prestige Coil System |
| Bolton Medical INC | $9.45 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$335,826.42 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.